Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia clinical trials

Explore recruiting cytologic or molecular relapsed refractory cd38 positive t cell acute lymphoblastic leukemia clinical trials.

Recruiting cytologic or molecular relapsed refractory cd38 positive t cell acute lymphoblastic leukemia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter, single-arm phase II study to assess the safety, tolerability, and efficacy of Isatuximab in adult patients with cytologic or molecular relapsed/refractory CD38 positive T-cell acute lymphoblastic leukemia

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia trials by city

Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Toronto Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Vancouver Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Montreal Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Calgary Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Edmonton Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Ottawa Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Winnipeg Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Quebec City Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Hamilton Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Kitchener Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in London Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Halifax Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in New York Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Los Angeles Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Chicago Cytologic Or Molecular Relapsed Refractory Cd38 Positive T Cell Acute Lymphoblastic Leukemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease